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Fasciclin I is a lipid-linked cell-surface glycoprotein 
that can act as a homopbilic adhesion molecule in tissue 
culture cells. It is thought to be involved in growth 
cone guidance in the embryonic insect nervous system. 
To facilitate structure-function studies, we have gen-
erated Chinese hamster ovary (CHO) cell lines express-
ing high levels of cell surface grasshopper and Dro-
sophila fasciclin I. Grasshopper fasciclin I released by 
phospholipase C cleavage was purified on an immu-
noaffinity column and single crystals were obtained 
that diffracted to -5-A resolution. We also generated 
CHO and Drosophila S2 cell lines that produce a se-
creted form of fasciclin I. Fasciclin I expressed in S2 
cells contains significantly less carbohydrate than the 
protein expressed in CHO cells, and may therefore be 
more suitable for crystallization. Biochemical charac-
terization of purified fasciclin I indicates that the ex-
tracellular portion exists as a monomer in solution. 
Circular dichroism studies suggest that fasciclin I is 
primarily a-helical. Its structure is therefore different 
from other known cell adhesion molecules, which are 
predicted to be elongated P-sheet structures. This sug-
gests that fasciclin I may define a new structural motif 
used to mediate adhesive interactions between cell sur-
faces. 
Neural cell adhesion molecules determine many of the 
specific cell-cell interactions involved in the patterning of the 
nervous system. These include the pathway choices made by 
neuronal growth cones, bundling of neuronal processes, and 
synapse formation and rearrangement. Relatively little bio-
chemical information concerning the molecular details of the 
recognition properties of adhesion molecules is available, pri-
marily because they are membrane glycoproteins that are 
difficult to purify in large quantities. Although some of these 
molecules have been demonstrated to mediate homophilic 
adhesion when transfected into cells (1, 2), the possibility of 
heterophilic interactions with an unknown partner molecule 
is more difficult to test in a transfection assay. We report the 
development of an expression system to generate milligram 
amounts of a soluble form of an insect cell adhesion molecule, 
*This work was supported by the Howard Hughes Medical Insti-
tute (P. J. B.) and the National Institutes of Health (NS28182 to K. 
Z.}. The costs of publication of this article were defrayed in part by 
the payment of page charges. This article must therefore be hereby 
marked "advertisement" in accordance with 18 U.S.C. Section 1734 
solely to indicate this fact. 
:j: Present address: Dept. of Life Science, National Tsing Hua 
University, Hsinchu, Taiwan 300, Republic of China. 
§ Pew Scholar. 
II Recipient of a Young Investigator Award from the Cancer Re-
search Institute. 
fasciclin I, as a first step in a biochemical and structural 
characterization of this neural adhesion molecule. This 
expression system could potentially be used to produce any 
adhesion molecule in a form that can be linked to a solid 
support and used to affinity-purify possible heterophilic Ii· 
gand proteins. 
Several novel cell adhesion molecules have been identified 
using monoclonal antibodies against neuronal membrane pro· 
teins from grasshopper and Drosophila embryos. The three 
fasciclins are expressed on subsets of central nervous system 
axons and are candidates for molecules involved in growth 
cone guidance during embryonic development (3). Another 
adhesion molecule, neuroglian, is more widely expressed on 
neurons and glia (3). Fasciclin II and neuroglian are members 
of the immunoglobulin (lg)1 superfamily and have domain 
organizations identical to those of the vertebrate neural cell 
adhesion molecules N-CAM and Ll, respectively (4). Fasciclin 
III is distantly related to the lg superfamily (3, 5). Fasciclin I 
contains four related domains, each of approximately 150 
amino acids, that are not similar to other sequences in the 
current data bases (6). All four of the Drosophila molecules 
can function as homophilic adhesion molecules in transfected 
Drosophila Schneider 2 (82) cells, and cell aggregates express-
ing different fasciclins sort away from each other (3, 5, 7). 
In the embryo, Drosophila fasciclin I (72 kDa) and gras-
shopper fasciclin I (75 kDa) are expressed on the surfaces of 
all peripheral nervous system axons, a subset of central nerv-
ous system axons, and on some non-neuronal cells (6, 8, 9). 
Genetic evidence suggests that fasciclin I is involved in growth 
cone extension or guidance in the embryonic central nervous 
system. Flies bearing an apparent null mutation in the fasci· 
clin I (fas!) gene are viable and do not exhibit visible defects 
in the central nervous system axon array. However, embryos 
doubly mutant in fas/ and in abl, the Drosophila homolog of 
the Abelson tyrosine kinase proto-oncogene, have major de· 
fects in central nervous system axon pathways (10). This 
result suggests that fasciclin I and abl protein may be com-
ponents of partially redundant signal transduction pathways 
involved in axon guidance. 
We chose fasciclin I for our expression experiments because 
it has a novel primary sequence, and because it is linked to 
the cell surface by a glycosyl-phosphatidylinositol (GPI) link· 
age. This allows it to be released from the cell surface as a 
soluble molecule by treatment of intact cells with phosphati-
dylinositol-specific phospholipase C (Pl-PLC). We show that 
1 The abbreviations used are: Ig, immunoglobulin; CHO, Chinese 
hamster ovary; mAb, monoclonal antibody; PAGE, polyacrylamide 
gel electrophoresis; TBS, Tris-buffered saline; TBST, TBS-Tween; 
FPLC, fast protein liquid chromatography; aMEM, a minimum es-
sential medium; DSP, 3,3' -dithio-bis-propionic acid N-hydroxysuc-
cinimide ester; GPI, glycosyl-phosphatidylinositol; MSX, methionine 
sulfoximine; PI-PLC, phosphatidylinositol-specific phospholipase C. 
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grasshopper and Drosophila fasciclin I can be expressed i? a 
GPI-linked form at high levels on the surface of mammalian 
cells, and in a secreted form when the sequence is truncated 
before the start of the GPI addition signal. Levels of protein 
expression were increased using a glutamine synthetase-based 
amplifiable expression system developed at Celltech, Berk-
shire, United Kingdom (11). When secreted from or expressed 
on the surface of Chinese hamster ovary (CHO) cells, the 
molecule contains an extra 15 kDa of carbohydrate not found 
on fasciclin I from insect embryos. Milligram quantities of 
soluble expressed fasciclin I have been purified on an immu-
noaffinity column, and large single crystals have been ob-
tained. Perhaps because of the excess carbohydrate on the 
CHO-expressed protein, the crystals do not diffract to suffi-
cient resolution to allow a structure determination by x-ray 
crystallographic methods. Preliminary studies in which the 
truncated form of grasshopper fasciclin I was transfected into 
Drosophiki 82 cells show that the resulting secreted protein 
contains significantly less carbohydrate, which may make it 
more amenable to crystallization. Soluble fasciclin I expressed 
in CHO or 82 cells exists as a monomer in solution. This 
observation suggests that any homophilic interactions it me-
diates are of low affinity, or involve clusters of proteins on 
the cell surface. Circular dichroism analysis suggests that the 
structure of fasciclin I is primarily a-helical. This is in con-
trast to the predominantly ,6-sheet structures predicted for 
adhesion molecules that are members of the immunoglobulin 
superfamily (1, 2, 12) and/or contain fibronectin type III 
repeats (2). 
MATERIALS AND METHODS 
Reagents-Endoglycosidase F/N-glycosidase F was obtained from 
Boehringer Mannheim. The hybridoma cell line that produces 3Bll, 
a mouse monoclonal antibody against grasshopper fasciclin I (8), and 
rat anti-grasshopper fasciclin I antiserum were gifts of Michael J. 
Bastiani (University of Utah). The monoclonal antibody 6D8 against 
Drosophila fasciclin I ( 13) was the gift of Corey Goodman (University 
of California, Berkeley). Goat anti-mouse fluorescein-conjugated IgG 
and goat anti-mouse IgG-peroxidase conjugate were obtained from 
Cappel Products. Mouse anti-rat IgG-alkaline phosphatase conjugate 
for Western blots was from Boehringer Mannheim. Methionine sul-
foximine (MSX) and phospholipase C were from Sigma. The S2 cell 
line and the phsneo vector were gifts of Michael Jackson (Scripps 
Clinic). The pRmHa3 vector was the gift of Allan Bieber (Purdue 
University). All other chemicals were reagent-grade. 
Construction of Lipid-linked and Soluble Forms of Grasshopper 
Fasciclin l-Molecular cloning experiments were performed by stand-
ard methods (14). Lipid-linked forms of fasciclin I were constructed 
by introducing full-length cDNA clones encoding grasshopper and 
Drosophila fasciclin I (6) into the EcoRI site of the polylinker of the 
expression vector pBJ5 (15), generating plasmids pBJ5.Gfl and 
pBJ5.Dfl, respectively. The cDNA clones used for the constructions 
encoded type IV grasshopper fasciclin I and type II Drosophila fasci-
clin I (9), respectively. This nomenclature refers to the presence or 
absence of micro-exon sequences between domains 2 and 3. Type II 
Drosophiw fasciciin I contains the micro-exon sequence SFK, and 
type IV grasshopper fasciclin I contains the micro-exon sequence GF 
(9). The glutamine synthetase minigene from the Celltech vector 
pSVLGS.l was excised using Aatll and BamHI, the ends were filled 
in using T4 polymerase, and the resulting fragment was blunt-end 
cloned into the filled-in Xhol site ofpBluescript KS(+) (Stratagene). 
A 5.5-kilobase Xhol-Sall fragment containing the glutamine synthe-
tase minigene was then cloned into the unique Sall site of pBJ5.Dfl 
to generate pBJ5.GS.Dfl or into one of the two Sall sites of pBJ5.Gfl 
in a partial digest to obtain pBJ5.GS.Gfl. 
To obtain a secreted form of grasshopper fasciclin I, a stop codon 
followed by a BamHI site was inserted after residue 634 by site-
directed mutagenesis (16). pBJ5.GS.sGfl was generated by introduc-
ing an EcoRV-Notl fragment containing the modified cDNA into the 
XhoI (filled-in) and Notl sites of the polylinker of pBJ5.GS (17). 
For expression in insect cells, the modified cDNA encoding the 
truncated form of grasshopper fasciclin I was suhcloned into the 
EcoRI and BamHI sites of the polylinker of the expression vector 
pRmHa3 (18) to generate pRmHa3.sGfl. 
Cell Culture and Transfection-COS7 cells were grown in mono· 
layer culture in Dulbecco's modified Eagle's medium supplemented 
with 10% fetal bovine serum, 2 mM glutamine, and 100 units/ml 
penicillin/streptomycin (GIBCO or Irvine Scientific). CHO Kl cells 
were grown in a minimum essential medium (aMEM; Irvine Scien-
tific) supplemented with 10% fetal bovine serum, 2 mM glutamin:e, 
and 100 units/ml penicillin/streptomycin. S2 cells were grown m 
Schneider's medium (Sigma) supplemented with 12.5% fetal bovine 
serum, 2 mM glutamine, and 100 units/ml penicillin/streptomycin. 
For transient transfections, COS7 cells were transfected by the 
DEAE-dextran method (12 µg of DNA/60-mm 70% confluent plate) 
(19, 20). A 10% Me2SO shock for 2 min following transfection with 
DEAE-dextran was employed to increase expression levels. Three 
days after transfection, the cells were harvested, washed with phos-
phate-buffered saline, and suspended in homogenization buffer (20 
mM Tris, pH 7.5, 1 mM imidazole, 1 mM dithiothreitol, 1 mM MgCl2, 
20 mM sodium diphosphate, 1 mM phenylmethanesulfonyl fluoride, 1 
µM pepstatin, 1 µM leupeptin). The cell extracts were then subjected 
to a chloramphenicol acetyltransferase assay (21) to determine the 
effectiveness of the transient transfection, or were prepared for West-
ern blot analysis. 
The pBJ5.GS.Gf1 and pBJ5.GS.sGfl expression vectors were 
transfected into CHO cells by a liposome (Lipofectin)-mediated 
method (Bethesda Research Laboratories). Selection and amplifica-
tion of the glutamine synthetase gene were carried out according to 
the protocol established by Celltech. In brief, 200 µl ofDNA-Lipofec-
tin complexes (30 µg of DNA plus 80-100 µg of Lipofectin) were 
introduced into a 10-cm plate with 50% confluent cells cultured in 
1 % dialyzed fetal bovine serum, aMEM without glutamine. After 18-
24 h of incubation at 37 'C, the medium was replaced with 10% 
dialyzed fetal bovine serum, aMEM without glutamine and the in-
cubation continued for an additional 24 h. The cells were then split 
into six 96-well plates and selected with 25 µM MSX in 10% dialyzed 
fetal bovine serum, aMEM without glutamine. MSX-resistant clones 
were isolated 2 weeks later. Positive transfectants were recloned and 
amplified under 100-500 µM MSX in 10% dialyzed fetal bovine serum, 
aMEM without glutamine. For cells transfected with pBJ5.GS.Gf1, 
the highest expressing cell populations were selected by immunoflu-
orescence with 3Bll or flow cytometry of cells stained with 3Bll. 
For the selection of clones expressing high levels of the secreted form 
of protein, cell supematants were filtered through a nitrocellulose 
paper using a Minifold II slot blot system (Schleicher & Schuell 
model SRC072/0), and the presence of secreted fasciclin I was verified 
by immunostaining. The highest expressing cell lines were grown in 
a Cell Pharm II hollow-fiber bioreactor device (Unisyn Fibertec, San 
Diego, CA). 
For stable transfection using the insect expression system, 25 µg 
of pRmHa3.sGfl plus 2.5 µg of phsneo, a selection vector, were 
cotransfected into 82 cells (106 cells/ml) cultured in 10-cm plate (10 
ml of medium) using a calcium phosphate procedure (Stratagene). 
Two days after transfection, cells were split into two l 75-cm2 flasks 
and selected with 1.0-1.6 mg/ml G418 (GIBCO). After 2 weeks, cells 
were passaged for a few generations and cloned in soft agar.2 In brief, 
8 ml of wild type S2 cells (1()5 cells/ml) and transformed cells (100-
800 cells) in Schneider's medium, 12.5% fetal bovine serum, penicil-
lin/streptomycin, with 1.0-1.6 mg/ml G418 were pipetted onto one 
side of a 10-cm bacteriological-grade Petri dish, leaving most of the 
surface of the plate uncovered. Two ml of a 1.5 % molten agar solution 
(48 'C; Difeo 0142--02) were pipetted onto the opposite side of the 
Petri plate. The contents of the plate were mixed thoroughly by 
swirling, and the plates were allowed to solidify and sealed with 
parafilm. Within 2 weeks of culture at 26 ·c, clones became visible 
and were isolated and grown in individual wells of a 96-well plate. 
Expression of protein was induced for 2-3 days in serum-free medium 
containing 0.7 mM CuSO,, and supematants from individual clones 
were examined by Western blotting or using the Minifold II slot blot 
system. 
Gel Electrophoresis and Western Blot Analysis-Sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was per-
formed according to Laemmli (22). Protein transfer after SDS-PAGE 
to nitrocellulose paper was done at 100 V for 3 h in transfer buffer 
(25 mM Tris, 190 mM glycine, 10% methanol) (23). Blots were 
immersed in 5% nonfat dry milk in TBST solution (10 mM Tris-HCl, 
pH 8.0, 150 mM NaCl, 0.05% Tween 20) for 30 min and then incubated 
2 A. Bieber, unpublished data. 
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with the primary mAb (6D8) at dilution of 1:1000 with TBST. After 
1 h, the blots were washed for 10-15 min three times with TBST, 
twice with TBS (10 mM Tris-HCl, pH 8.0, 150 mM NaCl), and 
incubated with affinity-purified horseradish-peroxidase-conjugated 
goat anti-mouse IgG or mouse anti-rat (1:200, diluted with TBS, 
Cappel) for 30 min. After three washes with TBS, two with phosphate-
buffered saline, and one with 50 mM Tris, pH 7.6, the blots were 
visualized using a diaminobenzidine-hydrogen peroxide staining so-
lution (0.063 diaminobenzidine (w/v), 0.033 H20 2 (v/v) in 50 mM 
Tris, pH 7.6) until the bands were suitably dark (about 5 min). All 
procedures were carried out at room temperature. 
Flow Cytometric Analysis-Trypsinized cells (2 X 106 cells/sample) 
were incubated with mAbs in ascites fluid at a dilution of 1:100 for 
at least 15 min on ice, washed three times with phosphate-buffered 
saline, and incubated with fluorescein-conjugated goat anti-mouse 
IgG. After 15 min, cells were washed three times with phosphate-
buffered saline, resuspended in 1 ml of phosphate-buffered saline 
containing 0.023 sodium azide, and passed through a 50 µM filter. 
Flow cytometric analyses were carried out on Ortho Cytofluorograf 
50H with a Data General 2150 computer system. 
Enzymatic Characterization of Fasciclin /-Protein from trans-
fected cells and from 10-14-h-old Drosophila embryos were deglyco-
sylated with endoglycosidase F carried out according to the manufac-
turer's specifications (Boehringer Mannheim). Deglycosylated pro-
tein was analyzed on Western blots. 
Purified grasshopper fasciclin I from CHO cells was treated with a 
battery of proteases, including trypsin, chymotrypsin, elastase, and 
papain. The protein was mixed with each protease at a 100:1 (w/w) 
ratio in phosphate-buffered saline (pH 7.1) and incubated at 37 °C. 
Aliquots were withdrawn at 0, 30, 60, and 120 min, the reaction 
stopped by adding phenylmethanesulfonyl fluoride to 2 mM, and 
samples run on a 83 SDS-PAGE gel. 
For analytical assays, PI-PLC from Bacillus cereus (Boehringer 
Mannheim) was added to a final concentration of 1 unit/ml, and 
incubated for 1 h at 37 °C. For releasing fasciclin I from cells grown 
in the hollow fiber bioreactor device, phospholipase C containing PI-
PLC (Sigma P6135; 1 mg/ml) was injected into the cell site at a 50-
fold dilution for 3 h at 37 °C. 
35 S Metabolic Labeling-105 transfected cells expressing G PI-linked 
grasshopper fasciclin I were cultured overnight with 100 µCi of [35S] 
methionine. Cells were then washed and treated with PI-PLC. The 
resultant supernatants were concentrated 10-fold and were electro-
phoresed on a 103 SDS-PAGE gel. Gels were fixed and prepared for 
autoradiography using the EN3HANCE'" system according to the 
manufacturer's directions (Du Pont). 
N-terminal Amino Acid Sequencing-Cells from two 175-cm2 flasks 
were washed thoroughly and treated with PI-PLC, and the superna-
tants were concentrated 30-fold using an Amicon Centricon-30 (M, 
cutoff of 30,000). Concentrated supernatants were run on a 103 SDS-
PAGE gel, electroblotted in a Bio-Rad transblot system onto a 
polyvinylidene difluoride membrane (Millipore), and inserted in an 
Applied Biosystems model 4778 sequenator reaction cartridge. 
Purification of Soluble Grasshopper by Affinity Chromatography-
The 3Bll-protein A-coupled immunoaffinity column was prepared 
according to Harlow and Lane (24). Briefly, 5 ml of 3Bll ascites (2 
mg/ml 3Bll) were adjusted to pH 9.0, 3 M NaCl and then reacted 
with 3 ml of protein A beads (Pharmacia or Bio-Rad) for 1-2 h with 
gentle agitation. After coupling, beads were washed thoroughly with 
50 mM sodium borate, 3 M NaCl, pH 9.0, four times and were 
resuspended in 10 volumes of 0.2 M sodium borate, 3 M NaCl, pH 9.0. 
Cross-linking of 3Bll and protein A beads was done using 20 mM 
dimethyl pimelimidate (Pierce Chemical Co.) in 0.2 M sodium borate, 
3 M NaCl, pH 9.0 for 30 min. The reaction was stopped by washing 
once in 0.2 M ethanolamine (pH 8.0), and incubation was continued 
for additional 2 h. The beads were washed three times with phosphate-
buffered saline and resuspended in phosphate-buffered saline with 
0.043 sodium azide. 
To purify grasshopper fasciclin I, supernatants from transfected 
CHO or Drosophila cells (about 500 ml) were passed over the affinity 
column at a flow rate of 20 ml(h at 4 °C, and the column was washed 
with 500 ml of phosphate-buffered saline, 0.053 sodium azide. Fas-
ciclin I was then eluted with 0.1 M sodium acetate, pH 3.4. Fractions 
of 3 ml were collected in test tubes containing 0.5 ml of 1 M phosphate, 
pH 8.2, for immediate neutralization. Generally, about 1 mg of gras-
shopper fasciclin I was obtained per daily harvest from the Cell 
Pharm containing cells expressing the G Pl or secreted form of gras-
shopper fasciclin I. About 0.5 mg of protein was obtained from 1 liter 
of S2 cells (5 x 106 cells/ml) after induction by 0. 7 mM copper sulfate 
for 4 days. 
Size-exclusion Chromatography-Following immunoaffinity chro-
matography, fasciclin I was concentrated to approximately 0.2-1 mg/ 
ml using a vacuum dialysis apparatus (Schleicher & Schuell) and an 
Amicon Centricon-30 (M, cutoff of 30,000). 50 µI of the concentrated 
protein were run on an FPLC Superose 12 column equilibrated with 
phosphate-buffered saline. 
Cross-linking-Purified grasshopper fasciclin I (20 µI at 0.01-0.02 
mg/ml) was treated for 30 min at 4 °C with 3,3' -dithio-bis-propionic 
acid N-hydroxysuccinimide ester (DSP; 40 mg/ml as a stock in 
dimethylformamide), a thiol-cleavable homobifunctional cross-link-
ing reagent, at concentrations ranging from 100 to 800 µg/ml. Cross-
linking reactions were stopped by addition of glycine to 50 mM, and 
samples were analyzed by Western blotting an SDS-PAGE gel run 
under reducing and nonreducing conditions. 
Crystallization-Crystallization trials were conducted in hanging 
drops using the method of vapor diffusion (25). Hanging drops of 
grasshopper fasciclin I (4.2-4.6 mg/ml) in 10 rnM Hepes, 0.023 NaN3, 
pH 7.5, were prepared by mixing equal volumes of the protein and 
the well precipitant on a coverslip, which was then inverted and 
equilibrated over a well (24-well plate, Linbro) containing 1 ml of the 
undiluted precipitant. Crystals were grown in 1.84 M ammonium 
sulfate, pH 7.5-8.5, or 1.6 M Na,K phosphate, pH 7.5-8.5. 
Circular Dichroism-The spectrum of CHO-derived secreted gras-
shopper fasciclin I (0.21 mg/ml in 5 mM sodium phosphate, pH 7.5) 
was collected using a Jasco J-600 spectropolarimeter. A cuvette with 
an 0.1-cm path length was used, and the mean residue ellipticity 
(degrees·cm2/dmol) was determined assuming a mean residue weight 
of 141. All spectra were recorded at room temperature from 260 to 
185 nm and were determined as the average of five scans. 
RESULTS 
Expression of GP I-linked and Soluble Forms of Fasciclin I 
in Mammalian and Insect Cell Lines-To express fasciclin I 
in mammalian cells, full-length cDNAs encoding the gras-
shopper and Drosophila fasciclin I proteins (6) were subcloned 
into the expression vector pBJ5 (15, 26), which contains a 
strong SV40/HTLV-1 hybrid promoter, as well as the SV40 
origin of replication. The fasciclin I expression plasmids were 
transiently transfected into COS7 cells, in which plasmids 
bearing SV 40 origins are efficiently replicated. After 3 days, 
cells transfected with the grasshopper fasciclin I plasmid were 
analyzed by immunofluorescent staining with the mAb 3Bll, 
which recognizes grasshopper fasciclin I. 1-5% of the cells 
displayed bright surface staining (data not shown). 
COS7 cells transfected with the Drosophila fasciclin I plas-
mid were treated with PI-PLC, and samples of supernatant 
and membranes were analyzed for the presence of fasciclin I 
by Western blotting with the mAb 6D8. Almost all of the 
fasciclin I appeared in the supernatant fraction, indicating 
that it could be released from the transfected cells by PI-PLC 
(data not shown). Because only a limited amount of antiserum 
capable of recognizing grasshopper fasciclin I on a Western 
blot was available, a comparable experiment was not per-
formed on COS7 cells transfected with the grasshopper fas-
ciclin I plasmid. However, similar data were obtained for 
grasshopper fasciclin I expressed in CHO cells (see below). 
Having shown that fasciclin I could be expressed on the 
surface of mammalian cells, stable transformant lines were 
created in CHO cells. The glutamine synthetase minigene was 
first subcloned into pBJ5.Gfl and pBJ5.Dfl to create the 
plasmids pBJ5.GS.Gfl and pBJ5.GS.Dfl. The glutamine syn-
thetase gene can be used as a selectable marker and means of 
gene amplification in the presence of the drug MSX, a system 
developed at Celltech, Berkshire, United Kingdom (11). The 
glutamine synthetase-fasciclin I plasmids were introduced 
into CHO cells, and stable transformant lines were selected 
and amplified with increasing concentrations of MSX. Analy-
sis of the highest expressing grasshopper fasciclin I line by 
fluorescence-activated cell sorting using the mAb 3Bll 
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FIG. 1. Flow cytometric analysis of the lipid-linked form of 
grasshopper fasciclin I expressed on CHO cells. Staining of 
transfected cells by 3Bll mAb; secondary antibody is fluorescein-
labeled goat anti-mouse IgG. --, primary and secondary antibodies; 
- - -, secondary antibody alone; · · · , primary and secondary antibody 
staining after treatment with PI-PLC. 
showed t hat most of the fasciclin I could be released from 
these cells by PI-PLC (Fig. 1) . 
We were unable to analyze the Drosophila fasciclin I-ex-
pressing lines by fluorescence-activated cell sorting because 
none of the existing anti-fasciclin I mAbs, which had been 
raised against denatured protein expressed in E. coli (13), 
were capable of staining the surfaces of live cells. Since these 
mAbs could not be used for purification by affinity chroma-
tography,3 we did not attempt purification of Drosophila fas-
ciclin I expressed in CHO cells. We have since used native 
protein released from the CHO-Drosophila fasciclin I line to 
generate new mAbs that stain live cells and can be used for 
affinity chromatography,4 reagents that should be useful for 
future studies. 
To characterize the CHO-derived grasshopper and Dro-
sophila fasciclin I, cells were metabolically labeled with (358] 
methionine, and supernatatants from cells after PI-PLC 
treatment were analyzed on a 103 SDS-PAGE gel (Fig. 2A) . 
The PI-PLC-released grasshopper and Drosophila fasciclin I 
migrated with apparent molecular masses of 90 and 85 kDa 
respectively, as compared to PI-PLC-released fasciclin I from 
insect embryos, which migrates with an apparent molecular 
mass of 75 kDa (grasshopper; Ref. 27) or 72 kDa (Drosphila; 
Ref. 13). A preparative amount of the 90-kDa band was 
isolated and subjected to N-terminal amino acid sequencing. 
The sequence obtained, KGEKSLEYKIRDDPDL, exactly 
corresponds to the N-terminal 16 residues of mature gras-
shopper fasciclin I (6, 27). The difference in molecular weight 
between CHO-derived grasshopper and Drosophila fasciclin I 
is probably due to the presence of six potential N-linked 
glycosylation sites in the grasshopper fasciclin I sequence, as 
compared to four in Drosophila fasciclin I (6). 
Complex oligosaccharides are added to proteins synthesized 
in cells from vertebrate hosts, as compared to small oligosac-
charide cores that are added to proteins synthesized in insect 
cells (28, 29). Thus, it seemed likely that the difference in 
molecular weight between the insect and CHO-derived fasci-
clin I proteins was due to additional glycosylation in CHO 
cells. To examine this possibility, PI-PLC-released protein 
from CHO lines was treated with endoglycosidase F and 
compared on a Western blot to similarly treated fasciclin I 
from Drosophila embryos. After deglycosylation, Drosophila 
fasciclin I from CHO cells comigrates with fasciclin I derived 
from embryos. Deglycosylated CHO-derived grasshopper fas-
ciclin I also migrates at a similar position, corresponding to 
3 W.-C. Wang, unpublished results. 
4 T.-Y. Kung and W.-C. Wang, unpublished results. 
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FIG. 2. Characterization of grasshopper fasciclin I ex-
pressed in CHO cells by 358 metabolic labeling (A) and degly-
cosylation with endoglycosidase F (B). A, autoradiogram of 10% 
SDS-PAGE gel run under reducing (R) and nonreducing (NR ) con-
ditions. Samples are supernatants from 105 transformed cells that 
were cultured overnight with [35S]methionine (100 !'Ci), and further 
incubated in the presence and absence of PI-PLC. C, untransfected 
CHO cells; D*, CHO cell line expressing Drosophila fasciclin I; G*, 
CHO cell line expressing grasshopper fasciclin I; -, no PI-PLC 
treatment; +, treated with PI-PLC. B, Western blots comparing 
molecular weights of deglycosylated CHO-derived Drosophila and 
grasshopper fasciclin I to fasciclin I derived from Drosophila embryos. 
Western blots of SDS-(8%) PAGE gels were probed with mAb 6D8 
(first eight lanes) or a rat anti-grasshopper fasciclin I antiserum (last 
four lanes). C, untransfected CHO cells; D*, Pl-PLC-released protein 
from CHO cell line expressing Drosophila fasciclin I; G*, PI-PLC-
released protein from CHO cell line expressing grasshopper fasciclin 
I; DM, membrane fractions of Drosophila embryo; DS, supernatant 
of Drosophila embryo membrane preparations after digestion of PI-
PLC; -, no endoglycosidase F treatment; +,treated with endoglyco-
sidase F. 
an apparent molecular mass of 68 kDa (Fig. 2B). 
For generation of ordered crystals, a chemically homoge-
neous protein is the preferred starting material. In order to 
eliminate a potential source of heterogeneity in purified fas-
ciclin I caused by the portion of the GPI tail remaining after 
PI-PLC digestion, a directly secreted form of the protein was 
also expressed in CHO cells. A stop codon was introduced by 
site directed mutagenesis (16) after amino acid 634 of gras-
shopper fasciclin I, which corresponds to the position presum-
ably encoding the beginning of the GPI linkage site in the 
fasciclin I cDNA (13, 30) , and the CHO expression vector was 
reconstructed. This plasmid, pBJ.GS.sGfl, was introduced 
into CHO cells and amplified lines selected as described above. 
The highest expressing lines were identified by slot blot 
analysis using the mAb 3Bll or by Western blotting of cell 
supernatants using the rat anti-fasciclin I antiserum. 
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The highest expressing CHO clones making the GPI-linked 
and the secreted versions of grasshopper fasciclin I were grown 
in a Cell Pharm II hollow fiber bioreactor device (Unisyn 
Fibertec, San Diego, CA) in the presence of 100 or 300 µM 
MSX. The expressed protein was isolated from the medium 
by passing it over a 3Bll mAb immunoaffinity column after 
a 3-h phospholipase C incubation in the case of the GPI-
linked fasciclin I, or with no incubation in the case of the 
truncated fasciclin I. Approximately 0.7-1.0 mg of pure pro-
tein per daily harvest from lines expressing either the GPI-
linked or the secreted form of fasciclin I were obtained. 
Purified GPI-linked fasciclin I migrates with an apparent 
molecular mass of -90 kDa (Fig. 3A) as compared to -88 
kDa for the secreted form (Fig. 3B) and is >90% pure as 
judged by a Coomassie stained SDS-PAGE gel (Fig. 3A). 
In an effort to express high levels of fasciclin I containing 
the physiological amount of carbohydrate for biochemical 
analysis, the cDNA encoding the secreted form of grasshopper 
fasciclin I was also introduced into a vector containing a 
metallothionein promoter that functions at high levels in 
copper-induced Drosophila Schneider cell lines (18). The fas-
ciclin I expression plasmid, pRmHa3.sGfl, was stably intro-
duced into Schneider 2 (S2) cells by cotransfection with a 
selection vector, phsneo (31). The highest-expressing clones 
were identified by Western blotting of cell supernatants, and 
secreted fasciclin I was purified as described above. About 0.5 
mg of fasciclin I/liter can be obtained from supernatants of 
these cells after copper induction, and this protein migrates 
with the expected molecular mass of 75 kDa on SDS-PAGE 
gels (Fig. 3B). 
Biochemical Characterization of Purified Fasciclin I -Stable 
fragments corresponding to domain structures can often be 
generated by proteolytic treatment of proteins containing 
multiple domains. To examine the stability and possible do-
main structure of purified fasciclin I, samples of purified 
protein were treated with trypsin, chymotrypsin, papain, and 
elastase. Fasciclin I was resistant to digestion by all of these 
proteases (data not shown), suggesting that the protein is 
folded into a stable structure without obvious flexible linker 
sequences between its domains. 
Drosophila fasciclin I has been shown to act as a homophilic 
adhesion molecule in tissue culture cells (7), so it was of 
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FIG. 3. A, 8D8-(103 ) PAGE gel of four fractions from affinity 
column purification of lipid-linked grasshopper fasciclin I expressed 
in CHO cells. Fasciclin I was eluted from the affinity column with a 
low pH buffer and four 3.0-ml fractions were collected. 10 µl from 
each fraction are shown on the gel. B, molecular weight comparison 
of three different forms of expressed grasshopper fasciclin I on 
Western blot of 8D8-(103 ) PAGE gel probed with a rat anti-gras-
shopper fasciclin I antiserum. Lane 11 secreted form expressed in 82 
cells; lane 2, secreted form expressed in CHO cells; lane 3, GPI-linked 
form expressed in CHO cells after treatment with PI-PLC. 
interest to determine whether this adhesion activity would 
correlate with oligomerization in solution. The oligomeric 
structure of purified grasshopper fasciclin I was examined by 
gel filtration and cross-linking studies. Concentrated fasciclin 
I from CHO or S2 cells migrates on a Superose 12 FPLC 
column in a position corresponding to a monomeric rather 
than a dimeric or higher oligomeric structure (Fig. 4A) . In 
addition, cross-linking of the S2-derived protein with the 
homobifunctional reagent DSP did not result in the appear-
ance of dimeric or other oligomeric species on SDS-PAGE 
gels (Fig. 4B). Thus, our data suggest that the extracellular 
portion of fasciclin I exists as a monomer in solution. Similar 
results have been observed for the extracellular portions of 
the homophilic adhesion molecules N-CAM (32) and cadher-
ins (32, 33). 
Crystallization and Structural Characterization of Fasciclin 
I-Grasshopper fasciclin I purified after PI-PLC cleavage 
crystallizes in the orthorhombic space group C2221 with unit 
cell dimensions 156 A x 352 A x 168 A. Based on average 
volume to mass ratios (34), the asymmetric unit of the crystal 
is estimated to contain between 2 and 8 molecules (corre-
sponding to solvent contents between 81%and23%). Typical 
crystals grow to a size of 0.5 mm X 0.3 mm x 0.3 mm (Fig. 5). 
Using nickel-filtered CuKa radiation from a rotating anode 
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FIG. 4. The extracellular portion of grasshopper fasciclin I 
exists as a monomer in solution, as demonstrated by gel filtra-
tion chromatography (A) and cross-linking (B). A , gel filtration 
profile (FPLC 8uperose 12 column in a phosphate-buffered saline 
solution, flow rate 0.4 ml/min) of purified grasshopper fasciclin I 
secreted from CHO cells (- - -) or from Drosophila 82 cells(--). B, 
8D8-(83 ) PAGE gels run under reducing (R) and nonreducing con-
ditions (NR) of CHO- or 82-derived fasciclin I cross-linked treated 
with a reducible homobifunctional cross-linking reagent, D8P, at 
different concentrations of cross-linking reagents indicated by num-
bers above the lanes (in µg/ ml). 
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FIG. 5. Crystals of CHO-derived grasshopper fasciclin I. 
Length of crystals is indicated by the bar. 
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FIG. 6. Far-UV CD spectrum of the secreted form of CHO-
derived grasshopper fasciclin I (0.21 mg/ml in 5 mM sodium 
phosphate, pH 7.0) expressed as ellipticity per mean residue. 
x-ray generator, the crystals diffract to -5 A with anisotropic 
diffraction in one direction to 3.5 A. Crystals of secreted 
grasshopper fasciclin I expressed in CHO cells are isomor-
phous and do not diffract to higher resolution. We did not 
obtain sufficient amount of secreted fasciclin I from the S2 
expression system for crystallization trials. 
To obtain information regarding the secondary structure 
content of fasciclin I, the far-UV CD spectrum of fasciclin I 
was analyzed. As shown in Fig. 6, the CD spectrum of fasciclin 
I is characterized by a positive peak at 195 nm followed by 
deep negative doublets at 208 nm and 220 nm, indicating a 
strong a-helical component. The ellipticity of a protein at any 
given wavelength in the far-UV region results from the sum 
of the contributions from the secondary structural elements 
within the molecule, thus allowing the estimation of the 
amounts of a -helix, ,(:I-sheet, ,(:I-turn, and irregular structure 
from the CD spectrum in this region (35). Based on an 
equation developed by Greenfield and Fasman (1969) , the a-
helical content of fasciclin I is calculated as 43% (36). A 
similar estimate of the percentage helical structure is obtained 
using the algorithm of Chang (37), in which analysis of the 
fasciclin I CD spectrum predicts 37% a-helix, 0% ,(:I-sheet, 
19% ,(:I-turn, and 34% irregular structure. These results indi-
cate that fasciclin I, unlike the adhesion molecules that are 
members of the immunoglobulin gene superfamily (1, 2) or 
contain fibronectin type III repeats (2, 38), is likely to contain 
a significant portion of a-helical structure. 
DISCUSSION 
Although grasshopper and Drosophila fasciclin I are closely 
related (6), only Drosophila fasciclin I has been demonstrated 
to mediate homophilic adhesion in tissue culture cells (7), and 
it is unclear whether homophilic adhesion is the primary 
function of fasciclins in vivo. After our experiments were 
initiated, it was found that S2 cells expressing grasshopper 
fasciclin I do not aggregate convincingly.3·5 Thus, the func-
tionality of purified grasshopper fasciclin I cannot be assayed 
by inhibition of cell aggregation. Two possible explanations 
for the failure of grasshopper fasciclin I expressing cell lines 
to aggregate are as follows: (i) other components in the S2 
cells are required for aggregation, and these do not interact 
effectively with the heterologous grasshopper fasciclin I pro-
tein (grasshopper and Drosophila fasciclin I are only 48% 
identical in sequence; Ref. 6). The recent observation that 
cytoskeletal catenin molecules are necessary for aggregation 
of cadherin-expressing cells is an example of a requirement 
for a protein in addition to a cell surface adhesion molecule 
for demonstration of adhesion (39). (ii) Both Drosophila and 
grasshopper fasciclin I exist in three different forms. These 
forms differ by the inclusion of 2, 3, or 6 amino acids encoded 
by micro-exons between the second and third domains (9). 
Drosophila fasciclin I has either no micro-exon sequence (+ 0 
form), the first micro-exon sequence (SFK; +3 form) , or both 
micro-exon sequences (SFKFMN; +6 form). Grasshopper 
fasciclin I exists as the +0 and +3 (SFK) forms and an 
additional form containing only a second micro-exon sequence 
(GF; +2 form) . No +6 form exists for grasshopper fasciclin I. 
Seeger and Goodman5 have shown that Drosophila +0 and +3 
fasciclin I mediate homophilic adhesion in S2 cells, but +6 
does not, or does so much more weakly. The +2 form of 
grasshopper fasciclin I, which was the form originally cloned 
(6) and the one that has been used for all expression and 
aggregation experiments, may be equivalent to Drosophila +6. 
Thus, this form of fasciclin I may have a function other than, 
or in addition to, homophilic adhesion. To look for other 
activities of the purified fasciclin I, we added it to grasshopper 
embryo cultures in an attempt to perturb the formation of 
axon tracts. However, no obvious effects were observed.6 
Despite the lack of a functional assay for grasshopper 
fasciclin I protein, we are confident that the molecule we have 
purified is correctly folded. Five lines of evidence support this 
conclusion. (i) Purified fasciclin I is resistant to digestion by 
several different proteases (see "Results"), the behavior of a 
compact globular protein rather than an aberrantly folded or 
denatured protein. (ii) The purified protein migrates as a 
sharp peak corresponding to a monomer on a gel filtration 
column (Fig. 4A ), while partially folded or denatured proteins 
migrate as broad peaks or elute in the void volume due to 
aggregation. (iii) The CD analysis shows a spectrum charac-
teristic of a -helical structure, not of a random coil (Fig. 6), 
and the spectrum converts to random coil in the presence of 
guanidine hydrochloride (data not shown). (iv) We have ob-
tained crystals of fasciclin I. Crystallization of a protein 
requires an array of identically shaped molecules, whereas 
unfolded or aberrantly folded molecules (which exist as a 
mixture of species) cannot be crystallized. (v) The 3Bll mAb 
used to purify the protein, which does not recognize denatured 
fasciclin I (8) ,3 can immunoprecipitate purified fasciclin I 
after elution from a 3Bll column, and purified fasciclin I 
rebinds to this column (data not shown). 
Results from gel fi ltration chromatography and cross-link-
ing studies suggest that the extracellular portion of grasshop-
5 M. Seeger and C. S. Goodman, personal communication. 
6 B. Condron, M. Bastiani, and W.-C. Wang, unpublished results. 
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per fasciclin I is a monomer in solution. Thus, we do not 
observe an oligomerization activity in solution that correlates 
with the homophilic adhesion activity of Drosophila fasciclin 
I expressed on the surface of S2 cells (7). Similarly, formation 
of dimers or polymers of isolated extracellular domains of 
other homophilic adhesion molecules such as the cadherins 
(32, 33), or N-CAM (32) have never been observed. These 
results suggest that the homophilic interactions mediated by 
these adhesion molecules are of low affinity, and/or involve 
clusters of proteins on the cell surface. In the case of gras-
shopper fasciclin I, the lack of oligomerization is consistent 
with the lack of homophilic adhesion activity displayed by 
grasshopper fasciclin I in S2 cells.3•5 
Crystals of purified fasciclin I do not diffract to a resolution 
sufficient for the determination of an atomic resolution struc-
ture. This may be due to the large amount of excess carbo-
hydrate on the CHO-derived protein as compared to the 
amount of carbohydrate on fasciclin I expressed in insect 
cells. In an attempt to obtain fasciclin I with the physiological 
amount of carbohydrate, we expressed a secreted version of 
grasshopper fasciclin I in Drosophila S2 cells. However, be-
cause of low expression of fasciclin I in S2 lines, we have been 
unable to obtain sufficient protein bearing the normal amount 
of carbohydrate for extensive crystallization trials. 
In the absence of high resolution structure information, an 
analysis of its circular dichroism spectrum was performed to 
allow us to compare the secondary structure composition of 
fasciclin I to that of other adhesion molecules. A number of 
adhesion molecules mediating interactions in the nervous and 
the immune systems consist of a series of repeated ti-sheet 
domain structures. For example, the extracellular domains of 
N-CAM and fasciclin II are composed of five immunoglobulin 
C2-like domains followed by two fibronectin type III repeats 
(3, 40). ICAM-1, which interacts with the integrin LFA-1 on 
T cells, contains five immunoglobulin variable-like domains 
in its extracellular portion (41). The immunoglobulin variable 
domain fold has been well-characterized as a two ti-sheet 
structure linked by a disulfide bond, and the crystal structure 
of a fragment of CD4 ( 42, 43) illustrates its use by an adhesion 
molecule that is a member of the immunoglobulin superfam-
ily. Fibronectin type III repeats are also ti-sheet structures, as 
predicted (44) and verified by the recent crystal structure of 
the human growth hormone receptor (38). A combination of 
electron microscopic studies (32, 41) with crystallographic 
studies of CD4 (42, 43, 45) suggest that adhesion molecules 
that are immunoglobulin superfamily members are likely to 
have extended structures with flexible linker regions between 
domains. 
The primary sequence of fasciclin I suggests that it consists 
of four related domains arranged in tandem on a single 
polypeptide chain, similar to the domain organization of CD4 
( 46), but the fasciclin I repeats do not have homology to 
immunoglobulin domains or to any other protein in the cur-
rent data bases (6). An analysis of the circular dichroism 
spectrum of purified grasshopper fasciclin I suggests that it is 
a predominantly a-helical protein, with little or no contribu-
tion from /1-structure. Based upon the 48% sequence identity 
between Drosophila and grasshopper fasciclin I (6), the a-
helical structure demonstrated for the grasshopper protein is 
expected to be shared by the Drosophila homolog as well (47). 
These results suggest that the structure of fasciclin I is 
substantially different than the structures of other inverte-
brate and vertebrate adhesion molecules, and that it may 
mediate adhesion through use of a novel structural motif. A 
human protein related to fasciclin I has been found, 7 demon-
strating the existence of a vertebrate molecule using this 
structural motif. So far, a function in mediating homophilic 
adhesion has been demonstrated for two of the three forms of 
Drosophila fasciclin I, but the functions of the other forms of 
insect fasciclin I and of the human fasciclin I-related protein 
are unknown. It is likely that additional molecules will be 
found in both vertebrate and invertebrate systems that use a 
helical motif to mediate adhesive interactions, and it will be 
of interest to define their mode of interaction and function. 
The experiments described here are the initial steps toward a 
molecular characterization of this new family of proteins. 
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